Skip links

News Articles

MED ADITUS NEWS: Appointment of Robert A. Blouin as President & Chief Executive Officer and Launch of Subsidiary, Med Aditus Pharmaceuticals, Inc.

FOR IMMEDIATE RELEASE Media Contact: Chiara Canzi Chief Communications Officer [email protected] (434) 249-5930 www.medaditus.org Med Aditus International Announces Appointment of Robert A. Blouin as President & Chief Executive Officer and Launch of Subsidiary, Med Aditus Pharmaceuticals, Inc.   RESEARCH TRIANGLE PARK, NC, (November 16, 2023)

WHO initiative signs new licensing agreements on COVID-19 technologies

The COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual property (IP), knowledge and innovations has announced three new licensing agreements acquired through the Medicines Patent Pool (MPP). The agreements include the following licenses to transfer know-how, materials and clinical data

KENYA: Cabinet approves 3 new funds to replace NHIF

KAKAMEGA, Kenya, Aug 30 – Cabinet has approved the establishment of three funds that will replace the National Hospital Insurance Fund (NHIF). A cabinet dispatch says the meeting chaired by President William Ruto okayed the Primary Healthcare Fund, Social Health Insurance Fund, and Emergency, Chronic

Rwanda welcomes Africa’s first mobile vaccine-production units

Six mobile vaccine-production units developed by German pharmaceutical company BioNTech have arrived in Rwanda. This is the first such shipment to Africa as the continent seeks to boost local production of mRNA vaccines. Advertising The units, made from recycled shipping containers, arrived in the capital

Q&A: Neglected diseases face final funding hurdle

By: Ogechi Ekeanyanwu and Jackie Opara Neglected tropical diseases (NTDs) – a set of 20 diseases including river blindness and sleeping sickness – affect more than a billion people globally, with Africa accounting for almost 40 per cent of the global burden. While Africa is